Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer Disease Interventions: Drug: neflamapimod; Other: placebo Sponsors: EIP Pharma, LLC; Worldwide Clinical Trials; VU University Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials